Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 09-2013 | |
| Sales | 1,295 | 495 | 2,935 | 0 | 9,051 |
| Gross Profit | 1,295 | 495 | 2,935 | N/A | 9,051 |
| Operating Expenses | 12,341 | 14,497 | 7,078 | 0 | 7,318 |
| Operating Income | -11,046 | -14,002 | -4,143 | N/A | 1,732 |
| Interest Expense | 555 | 706 | 358 | 0 | 901 |
| Other Income | 0 | 0 | 0 | 0 | -14,125 |
| Pre-tax Income | -11,601 | -14,708 | -4,501 | 0 | -13,294 |
| Income Tax | 120 | -726 | 406 | N/A | 439 |
| Net Income Continuous | -11,721 | -13,981 | -4,907 | N/A | -13,733 |
| Minority Interests | -380 | N/A | N/A | N/A | N/A |
| Net Income | $-11,340 | $-13,981 | $-4,907 | $N/A | $-13,733 |
| EPS Basic Total Ops | -208.00 | -257.60 | -123.20 | N/A | N/A |
| EPS Basic Continuous Ops | -195.59 | -238.56 | -83.73 | N/A | N/A |
| EPS Diluted Total Ops | -208.00 | -257.60 | -123.20 | N/A | N/A |
| EPS Diluted Continuous Ops | -195.59 | -238.56 | -83.73 | N/A | N/A |
| EBITDA(a) | $-10,625 | $-13,783 | $-3,921 | $N/A | $1,732 |